Our Services
Market Access
Intelligence & Insights
Commercial Strategy
How we work
Centre of Excellence
Vision
Festival of Pharma
Expert Network
Diamond Insights TV
Series 1: CAR-T-OGRAPHY
Series 2: Digital Domination
Our Team
Careers
Explore Opportunities
Why Join Eradigm?
Who we are
Our Values
What Does a Consultant Do?
Life Science Consulting Jobs
Ethos and Benefits
Insights
Articles
Experts Circles
White Papers
Contact Us
UK HEAD OFFICE
+44 (0) 203 929 0534
Our Services
Market Access
Intelligence & Insights
Commercial Strategy
How we work
Centre of Excellence
Vision
Festival of Pharma
Expert Network
Diamond Insights TV
Series 1: CAR-T-OGRAPHY
Series 2: Digital Domination
Our team
Careers
Job Vacancies
Why Join Eradigm?
Who we are
Our Values
What Does a Consultant Do?
Life Science Consulting Jobs
Ethos and Benefits
Insights
Articles
Experts Circles
White Papers
Contact Us
UK HEAD OFFICE
+44 (0) 203 929 0534
p
Eradigm Consulting
Fora, 180 Borough High Street,
London SE1 1L
+44 (0) 203 929 0534
Insights, news and articles from the frontline of Pharma
All
Articles
White Papers
Latest News
August 18 2022
Is DiGA the way forward? – What does the optimal reimbursement model look like?
3 min read
August 18 2022
Women’s health is greater than Femtech – and the opportunity is huge.
4 min read
August 18 2022
AI-Powered Drug Discovery – buzzword or the future?
3 min read
August 9 2022
Gene Therapies: Can the industry keep up its momentum or will it burn out?
5 min read
August 9 2022
The cutting edge of biotech: the continuous drive to achieve next-gen greatness
5 min read
August 9 2022
Access for one, access for all: if no longer rare, how will biotech ensure sustainable access to CGTs to the masses?
6 min read
July 18 2022
Throw it against the wall and see what sticks; Players testing their ‘new’ molecular entities in numerous immuno-oncology or autoimmune settings concurrently
3 min read
July 18 2022
Assembling all the bits and pieces – tackling capacity constraints for the successful rollout for neurological therapies
3 min read
July 18 2022
Venturing Into the Unknown: How Pharma is Embracing Neuroscience R&D After Decades of Failure
3 min read
Page 2 of 6
1
2
3
4
5
6